Speciality Medicines Secures Ethiopian Approval For Two New Products

Speciality Medicines secured Ethiopian regulatory approval for Olazyn 5 and Diazem 5, taking its Ethiopia portfolio to 12 and total registered products to 14, each valid five years. Context: this resolves part of the company’s international-registration expansion programme.